Equities

Work Medical Technology Group Ltd

WOK:NAQ

Work Medical Technology Group Ltd

Actions
  • Price (USD)4.63
  • Today's Change0.185 / 4.17%
  • Shares traded33.26k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 18:33 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Work Medical Technology Group Ltd's revenues fell -31.18% from 19.71m to 13.57m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from 865.21k to 112.03k, a -87.05% decrease.
Gross margin30.54%
Net profit margin0.47%
Operating margin3.04%
Return on assets0.23%
Return on equity1.13%
Return on investment0.63%
More ▼

Cash flow in USDView more

In 2023, Work Medical Technology Group Ltd increased its cash reserves by 111.69%, or 863.86k. The company earned 2.21m from its operations for a Cash Flow Margin of 16.29%. In addition the company used 583.30k on investing activities and also paid 728.72k in financing cash flows.
Cash flow per share0.112
Price/Cash flow per share39.88
Book value per share0.6811
Tangible book value per share0.6123
More ▼

Balance sheet in USDView more

Work Medical Technology Group Ltd has a Debt to Total Capital ratio of 44.59%.
Current ratio1.17
Quick ratio0.9265
Total debt/total equity0.8951
Total debt/total capital0.4459
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items dropped -87.05%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
-87.06
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.